Filter Results:
(299)
Show Results For
- All HBS Web
(299)
- People (1)
- News (83)
- Research (187)
- Multimedia (4)
- Faculty Publications (124)
Show Results For
- All HBS Web
(299)
- People (1)
- News (83)
- Research (187)
- Multimedia (4)
- Faculty Publications (124)
- December 2012
- Teaching Note
Gene Patents (A) (TN)
By: Richard G. Hamermesh and Matthew Preble
This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details
- September 2000
- Case
Novartis Agricultural Discovery Institute (A)
Steve Briggs, a PhD biologist, is asked to propose a strategy to take global life-science giant Novartis into the rapidly expanding field of plant genomics. View Details
Keywords: Design; Plant-Based Agribusiness; Genetics; Infrastructure; Biotechnology Industry; Agriculture and Agribusiness Industry
West, Jonathan, and Christian G. Kasper. "Novartis Agricultural Discovery Institute (A)." Harvard Business School Case 601-010, September 2000.
- Web
Benjamin Chang | MBA
this future, and through this program, I hope to learn from and empower each other to move the world forward. Tech areas of interest: Synthetic biology, AI/ML, genetic engineering, space exploration, social impact tech Formative... View Details
- June 2003 (Revised March 2008)
- Case
Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene
By: Regina E. Herzlinger and Marc Aquino
Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details
Keywords: Health Disorders; Research and Development; Genetics; Biotechnology Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Marc Aquino. "Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene." Harvard Business School Case 303-044, June 2003. (Revised March 2008.)
- 10 Dec 2010
- News
Notes from the Trenches
Executive Director Mike Roberts, the lineup lost no time in getting down to brass tacks with the SRO student crowd of would-be entrepreneurs. Paris Wallace (MBA ’07) of Good Start Genetics noted that the BPC is an effective way to meet... View Details
- 24 Apr 2014
- News
Founding a bone marrow donor bank that saves thousands of lives
in the world, helping thousands of patients with leukemia and other life-threatening diseases in need of matching donors to save their lives. Because a close genetic match is necessary, even with a registry of millions, 6 out of 10... View Details
- Web
Timeline - Race, Gender & Equity
bankruptcy or bad debts 1985 USDA approves the sale of the first genetically altered organism 1986 Immigration Reform and Control Act prohibits employers with more than three employees from discriminating against anyone (except... View Details
- 01 Aug 2001
- News
Ray A. Goldberg (MBA '50)
companies and countries worldwide and, before retiring in 1997, had taught some seven thousand Harvard MBA students and ten thousand Executive Education participants. Most recently, Goldberg has focused on the impact that advances in View Details
- 27 Jul 2022
- News
Alumna-Led Reproductive Health Startup Raises $4.7 Million
Thain Gioia and her cofounder realizing there were serious deficits in the information offered during their pregnancies. “Personally, my daughter was born with a cleft lip—though I had no risk factors or genetic link—it really knocked me... View Details
- 1997
- Chapter
Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond
By: Josh Lerner and Robert P. Merges
Keywords: Patents; Applications and Software; Genetics; Information Technology Industry; Biotechnology Industry
Lerner, Josh, and Robert P. Merges. "Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond." In Competing in the Age of Digital Convergence, edited by D. B. Yoffie, 301–324. Boston: Harvard Business School Press, 1997.
- 16 Mar 2015
- News
A Sustainable Approach to Physics Education
Ogden, who grew up in a working-class family, recalls the power of his own education, leading up to his time at HBS, where the idea of paying it forward was part of the School’s DNA. “There’s something in the genetic code of the School... View Details
- Web
Jason Cho | MBA
program, I aspire to advance my vision of imagining reckless miracles and uncovering the countless opportunities it will bring. Tech areas of interest: AI in Biology, Biotechnology, Brain-Computer Interface, Genetic Engineering, Medical... View Details
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's View Details
Keywords: Julia Hanna
- 25 Jul 2011
- Research & Ideas
How Disruptive Innovation is Remaking the University
against the same criteria applied to his or her predecessor. The way things are done is determined not by individual preference but by institutional procedure written into the genetic code. There is evolution in the university, though its... View Details
- 01 Sep 2008
- News
Mara Aspinall
1,500-person division is a leader in the emerging field of personalized medicine, which treats cancer and other diseases with customized therapies that take into account the patient’s specific genetic traits. With HBS professor Richard... View Details
- 01 Mar 2017
- News
Alumni Take Cold Calls in New York City
focused on 23andMe, whose sale of genetic testing kits directly to consumers was challenged by the Food & Drug Administration. Quelch, who coauthored the case, is also on the faculty of the Harvard T.H. Chan School of Public Health. The... View Details
- 01 Jun 2018
- News
Floor It
The sci-fi future for cancer treatment has become a reality, with breakthrough therapies that can use a cancer patient’s genetic information to create personalized treatments or employ the body’s immune response to treat disease. But for... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- June 2005 (Revised July 2006)
- Background Note
Note on the Convergence Between Genomics & Information Technology
By: David B. Yoffie, Dharmesh M Mehta and Rachel Sha
Focuses on the convergence between the genomics and semiconductor industries, in particular organ printing, DNA computing, biomolecular sensory networks, and DNA microarrays. Explains what this newly converged world looks like based on current research and findings in... View Details
Keywords: Genetics; Information Technology; Business Model; Disruptive Innovation; Biotechnology Industry; Information Technology Industry; Semiconductor Industry; Medical Devices and Supplies Industry
Yoffie, David B., Dharmesh M Mehta, and Rachel Sha. "Note on the Convergence Between Genomics & Information Technology." Harvard Business School Background Note 705-500, June 2005. (Revised July 2006.)
- February 2024
- Article
Are Many Sex/Gender Differences Really Power Differences?
By: Adam D. Galinsky, Aurora Turek, Grusha Agarwal, Eric M. Anicich, Derek D. Rucker, Hannah Riley Bowles, Nira Liberman, Chloe Levin and Joe C Magee
This research addresses the long-standing debate about the determinants of sex/gender differences. Evolutionary theorists trace many sex/gender differences back to natural selection and sex-specific adaptations. Sociocultural and biosocial theorists, in contrast,... View Details
Galinsky, Adam D., Aurora Turek, Grusha Agarwal, Eric M. Anicich, Derek D. Rucker, Hannah Riley Bowles, Nira Liberman, Chloe Levin, and Joe C Magee. "Are Many Sex/Gender Differences Really Power Differences?" PNAS Nexus 3, no. 2 (February 2024).
- November 1999
- Case
E.I. du Pont de Nemours and Company (B)
DuPont must decide whether to launch a new non-GM (genetically modified) soybean that is tolerant to chemical sprays. In the face of rapid introductions of GM products by competitors, DuPont faces the challenge of ensuring the identity preservation of its new product... View Details
Keywords: Business Model; Customer Value and Value Chain; Genetics; Agriculture and Agribusiness Industry
West, Jonathan, and Christian G. Kasper. "E.I. du Pont de Nemours and Company (B)." Harvard Business School Case 600-051, November 1999.